OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID ‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries
Edward Burn, Xintong Li, Kristin Kostka, et al.
Pharmacoepidemiology and Drug Safety (2022) Vol. 31, Iss. 5, pp. 495-510
Open Access | Times Cited: 37
Edward Burn, Xintong Li, Kristin Kostka, et al.
Pharmacoepidemiology and Drug Safety (2022) Vol. 31, Iss. 5, pp. 495-510
Open Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Jörg B. Schulz, Peter Berlit, Hans‐Christoph Diener, et al.
Annals of Neurology (2021) Vol. 90, Iss. 4, pp. 627-639
Open Access | Times Cited: 133
Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study
Edward Burn, Talita Duarte‐Salles, Sergio Fernández‐Bertolín, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 8, pp. 1142-1152
Open Access | Times Cited: 87
Edward Burn, Talita Duarte‐Salles, Sergio Fernández‐Bertolín, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 8, pp. 1142-1152
Open Access | Times Cited: 87
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals
Kristýna Faksová, Donna Walsh, Yannan Jiang, et al.
Vaccine (2024) Vol. 42, Iss. 9, pp. 2200-2211
Open Access | Times Cited: 84
Kristýna Faksová, Donna Walsh, Yannan Jiang, et al.
Vaccine (2024) Vol. 42, Iss. 9, pp. 2200-2211
Open Access | Times Cited: 84
Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview
Amir Abbas Shiravi, Ali Ardekani, Erfan Sheikhbahaei, et al.
Cardiology and Therapy (2021) Vol. 11, Iss. 1, pp. 13-21
Open Access | Times Cited: 68
Amir Abbas Shiravi, Ali Ardekani, Erfan Sheikhbahaei, et al.
Cardiology and Therapy (2021) Vol. 11, Iss. 1, pp. 13-21
Open Access | Times Cited: 68
Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis
Prakash Bhuyan, Jennie Medin, Hugo Gomes da Silva, et al.
The Lancet (2021) Vol. 398, Iss. 10300, pp. 577-578
Open Access | Times Cited: 61
Prakash Bhuyan, Jennie Medin, Hugo Gomes da Silva, et al.
The Lancet (2021) Vol. 398, Iss. 10300, pp. 577-578
Open Access | Times Cited: 61
Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US
Xintong Li, Edward Burn, Talita Duarte‐Salles, et al.
BMJ (2022), pp. e071594-e071594
Open Access | Times Cited: 45
Xintong Li, Edward Burn, Talita Duarte‐Salles, et al.
BMJ (2022), pp. e071594-e071594
Open Access | Times Cited: 45
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study
Corinne Willame, Caitlin Dodd, Carlos E. Durán, et al.
Vaccine (2022) Vol. 41, Iss. 1, pp. 251-262
Open Access | Times Cited: 44
Corinne Willame, Caitlin Dodd, Carlos E. Durán, et al.
Vaccine (2022) Vol. 41, Iss. 1, pp. 251-262
Open Access | Times Cited: 44
Expert review on global real-world vaccine effectiveness against SARS-CoV-2
Sunate Chuenkitmongkol, Rontgene Solante, Erlina Burhan, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 9, pp. 1255-1268
Open Access | Times Cited: 39
Sunate Chuenkitmongkol, Rontgene Solante, Erlina Burhan, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 9, pp. 1255-1268
Open Access | Times Cited: 39
Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond
Václav Papež, Maxim Moinat, Erica A. Voss, et al.
Journal of the American Medical Informatics Association (2022) Vol. 30, Iss. 1, pp. 103-111
Open Access | Times Cited: 29
Václav Papež, Maxim Moinat, Erica A. Voss, et al.
Journal of the American Medical Informatics Association (2022) Vol. 30, Iss. 1, pp. 103-111
Open Access | Times Cited: 29
COVID-19 Therapeutics: Use, Mechanism of Action, and Toxicity (Vaccines, Monoclonal Antibodies, and Immunotherapeutics)
Michael Chary, Alexander F. Barbuto, Sudeh Izadmehr, et al.
Journal of Medical Toxicology (2023) Vol. 19, Iss. 2, pp. 205-218
Open Access | Times Cited: 19
Michael Chary, Alexander F. Barbuto, Sudeh Izadmehr, et al.
Journal of Medical Toxicology (2023) Vol. 19, Iss. 2, pp. 205-218
Open Access | Times Cited: 19
Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis
Anastasia Phillips, Yannan Jiang, Donna Walsh, et al.
Vaccine (2023) Vol. 41, Iss. 42, pp. 6227-6238
Open Access | Times Cited: 17
Anastasia Phillips, Yannan Jiang, Donna Walsh, et al.
Vaccine (2023) Vol. 41, Iss. 42, pp. 6227-6238
Open Access | Times Cited: 17
Safety Monitoring of COVID ‐19 Vaccines: Perspective from the European Medicines Agency
Julie Durand, Jean‐Michel Dogné, Catherine Cohet, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 6, pp. 1223-1234
Open Access | Times Cited: 28
Julie Durand, Jean‐Michel Dogné, Catherine Cohet, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 6, pp. 1223-1234
Open Access | Times Cited: 28
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019–2020
Keran Moll, Bradley Lufkin, Kathryn R. Fingar, et al.
Vaccine (2022) Vol. 41, Iss. 2, pp. 333-353
Open Access | Times Cited: 20
Keran Moll, Bradley Lufkin, Kathryn R. Fingar, et al.
Vaccine (2022) Vol. 41, Iss. 2, pp. 333-353
Open Access | Times Cited: 20
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study
Oskar Gauffin, Judith S. Brand, Sara Hedfors Vidlin, et al.
Drug Safety (2023) Vol. 46, Iss. 12, pp. 1335-1352
Open Access | Times Cited: 11
Oskar Gauffin, Judith S. Brand, Sara Hedfors Vidlin, et al.
Drug Safety (2023) Vol. 46, Iss. 12, pp. 1335-1352
Open Access | Times Cited: 11
Risk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States
Vincent Lo Re, Noelle M. Cocoros, Rebecca A. Hubbard, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 71-89
Open Access | Times Cited: 4
Vincent Lo Re, Noelle M. Cocoros, Rebecca A. Hubbard, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 71-89
Open Access | Times Cited: 4
Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination
María Gordillo‐Marañón, Gianmario Candore, Karin Hedenmalm, et al.
Drug Safety (2024) Vol. 47, Iss. 7, pp. 607-615
Open Access | Times Cited: 4
María Gordillo‐Marañón, Gianmario Candore, Karin Hedenmalm, et al.
Drug Safety (2024) Vol. 47, Iss. 7, pp. 607-615
Open Access | Times Cited: 4
Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework
Colleen L. Lau, Helen J. Mayfield, Jane E. Sinclair, et al.
Vaccine (2021) Vol. 39, Iss. 51, pp. 7429-7440
Open Access | Times Cited: 27
Colleen L. Lau, Helen J. Mayfield, Jane E. Sinclair, et al.
Vaccine (2021) Vol. 39, Iss. 51, pp. 7429-7440
Open Access | Times Cited: 27
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial
Simbarashe Takuva, Azwidihwi Takalani, Ishen Seocharan, et al.
PLoS Medicine (2022) Vol. 19, Iss. 6, pp. e1004024-e1004024
Open Access | Times Cited: 18
Simbarashe Takuva, Azwidihwi Takalani, Ishen Seocharan, et al.
PLoS Medicine (2022) Vol. 19, Iss. 6, pp. e1004024-e1004024
Open Access | Times Cited: 18
Venous and Arterial Thromboembolic Events after COVID-19 During the Omicron Period in three European countries
Martí Català, Xintong Li, Annika M. Jödicke, et al.
Research Square (Research Square) (2025)
Closed Access
Martí Català, Xintong Li, Annika M. Jödicke, et al.
Research Square (Research Square) (2025)
Closed Access
Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research
Berta Raventós, Sergio Fernández‐Bertolín, María Aragón, et al.
Clinical Epidemiology (2023) Vol. Volume 15, pp. 969-986
Open Access | Times Cited: 9
Berta Raventós, Sergio Fernández‐Bertolín, María Aragón, et al.
Clinical Epidemiology (2023) Vol. Volume 15, pp. 969-986
Open Access | Times Cited: 9
Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases
Anna Ostropolets, Xintong Li, Rupa Makadia, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Anna Ostropolets, Xintong Li, Rupa Makadia, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Assessing heterogeneity of electronic health‐care databases: A case study of background incidence rates of venous thromboembolism
Martin Russek, Chantal Quinten, Valentijn M. T. de Jong, et al.
Pharmacoepidemiology and Drug Safety (2023) Vol. 32, Iss. 9, pp. 1032-1048
Open Access | Times Cited: 7
Martin Russek, Chantal Quinten, Valentijn M. T. de Jong, et al.
Pharmacoepidemiology and Drug Safety (2023) Vol. 32, Iss. 9, pp. 1032-1048
Open Access | Times Cited: 7
Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in England
Hannah Higgins, Nick Andrews, Julia Stowe, et al.
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 3, pp. e12698-e12698
Open Access | Times Cited: 10
Hannah Higgins, Nick Andrews, Julia Stowe, et al.
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 3, pp. e12698-e12698
Open Access | Times Cited: 10
Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
Azza Shoaibi, Gowtham Rao, Erica A. Voss, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 685-698
Open Access | Times Cited: 10
Azza Shoaibi, Gowtham Rao, Erica A. Voss, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 685-698
Open Access | Times Cited: 10
